Mon Health System gets go ahead for new $26.5M hospital in Bridgeport
The week of April 3, officials with Vandalia Health filed for a building permit to construct Vandalia Health Mon Harrison Neighborhood Hospital at Charles Pointe Crossing in Bridgeport.
"This week's filing of the hospital's building permit with the City of Bridgeport marks a key milestone in a process that began nearly three years ago in July 2022, when Mon Health
System filed for a Certificate of Need for the facility," states a press release. "The path to construction included extensive collaboration with Charles Pointe developers, Genesis Partners, the City of Bridgeport, Harrison County Commission and stakeholders within the county's tax increment financing district."
At a cost of $26.5 million, the new two-story hospital will be built in the rapidly-developing Charles Point Crossing on a parcel of land just past Menards. The 40,000-square-foot small format hospital is modeled after Vandalia Health Mon Marion Neighborhood Hospital, which opened in White Hall in 2022.
'Vandalia Health Mon Marion Neighborhood Hospital has become a model for delivering advanced medical services in a smaller, more accessible footprint. We've exceeded expectations in patient satisfaction, speed of care and operational efficiency, and have been recognized as having one of the shortest emergency room visit times in the nation,' said Dr. Christopher Edwards, emergency services director of Vandalia Health Mon Health System emergency medicine medical director and Vandalia Health Mon Marion and Mon Harrison Neighborhood Hospitals chief administrative officer.
'Our hospital's success has proven that neighborhood hospitals can offer the same quality of care as larger institutions — just closer to home. We're extremely excited to bring this quality, convenient care to the people of Harrison County and surrounding communities with the construction of Vandalia Health Mon Harrison Neighborhood Hospital.'
The first floor of the new Mon Harrison Neighborhood Hospital will feature 24/7 emergency care, including eight emergency rooms staffed by board-certified physicians who will provide comprehensive inpatient care. The first floor will contain 10 private inpatient rooms, pharmacy services, radiology services such as CT, MRI, ultrasound, X-ray, echocardiogram and more.
The second floor will be constructed as shell space reserved for future clinical or administrative expansion, and will be designed to address future needs of the community.
'This hospital is the result of incredible collaboration at every level,' said David Goldberg, president and CEO of Mon Health System and Davis Health System - Vandalia Health Northern
Region, and executive vice president of Vandalia Health. 'From the City of Bridgeport and Harrison County Commission to Genesis Partners and our partners in the TIF district — everyone came together with a shared vision to improve access to health care in Harrison County.
"We are deeply grateful for their support, partnership and unwavering commitment to bringing this much-needed facility to life for the people of Harrison County. With our new hospital, we cannot wait to deliver on our promise to provide exceptional care to this region. Mon Health is known far and wide and now as Vandalia Health, the breadth and depth of resources only enhance our ability to meet the needs of the community, one patient at a time.'
Construction will begin in spring 2025 and is anticipated to take just over a year, with architectural and engineering work already complete. Equipment has been ordered, and materials are in process for development this month.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
09-07-2025
- Time Business News
Practical Steps for Launching a Rehab Center Successfully
Every successful rehab center starts with a clearly defined purpose. Are you aiming to provide detox services, residential treatment, intensive outpatient programs (IOP), or all three? Pinpoint your target population—adults, adolescents, veterans, or individuals with co-occurring mental health disorders. From there, define the clinical approach: will you offer evidence-based treatments like CBT or DBT, or integrate holistic methods such as mindfulness and fitness therapy? Establishing a mission statement and selecting a treatment model early shapes the operational framework, guiding future decisions in staffing, programming, and facility design. Establishing a facility dedicated to recovery requires more than just good intentions—it demands careful planning, regulatory knowledge, and a strong business foundation. From selecting the right location to hiring qualified staff, every detail contributes to the success of your mission. Understanding how to start a rehab center involves navigating licensing requirements, developing treatment programs, and securing funding to sustain operations. Community engagement, ethical practices, and outcome-based care models further enhance credibility and effectiveness. With the right strategy and commitment, your center can become a transformative space for healing and hope, offering long-term support to those in need. Navigating legal and regulatory processes is a cornerstone of launching your center. Contact your state's Department of Health or Substance Abuse Services to understand licensure rules, inspection requirements, and documentation standards. You'll need to develop detailed protocols covering emergency procedures, medication management, staff qualifications, and client safety. If your state requires a Certificate of Need (CON), begin that process immediately—it can take months. Set up policies that ensure HIPAA compliance, from client records to telehealth sessions. Laying a legal foundation ensures that your operation starts—and stays—within the law. Your physical space should promote healing while fulfilling strict health and safety codes. Choose a location that meets zoning laws and is accessible for clients and staff alike. A residential treatment center needs multiple bedrooms, group areas, and outdoor spaces, while an outpatient center requires private therapy rooms and administrative offices. Make sure your building meets ADA accessibility requirements and includes safety features such as secure storage, sprinkler systems, and alarm protocols. The ambiance should be calm and therapeutic—soft lighting, natural elements, and a clutter-free design go a long way in creating a safe atmosphere. Staffing is one of the most influential elements of your center's reputation and success. Hire a clinical director with the experience and credentials to oversee treatment protocols and supervise therapists. Fill out your team with licensed counselors, social workers, addiction specialists, nursing staff, and case managers. For residential centers, 24/7 support staff may also be required. Administrative hires should include intake coordinators and billing experts with knowledge of behavioral health systems. Look for individuals who share your core values, understand trauma-informed care, and are committed to long-term recovery outcomes. Create a consistent and well-documented treatment structure. Develop daily schedules, phases of care, group curricula, and relapse prevention plans. Your programming should reflect your population's needs and align with payer expectations. Include a balance of individual therapy, group work, psychoeducation, medication management, and aftercare planning. Draft policies for client intake, risk assessments, progress reviews, and discharge. These protocols not only support clinical outcomes but are essential for insurance billing, compliance, and staff training. Financial systems are critical to keeping your rehab center operational. Choose an electronic medical record (EMR) platform tailored to behavioral health, with capabilities for clinical documentation, scheduling, and billing. Begin the credentialing process with Medicaid, Medicare, and commercial insurers early, as approval can take three to six months. Establish billing systems that manage claims submission, denials, and reimbursement tracking efficiently. A knowledgeable billing team—or third-party billing partner—can safeguard your cash flow and keep operations running smoothly. Build a marketing plan that communicates your center's unique strengths and builds trust. Your website should clearly explain services, showcase staff credentials, and offer an easy intake process. Use local SEO to ensure visibility when people search for nearby treatment options. Establish referral relationships with physicians, therapists, court systems, and hospitals. Host community seminars or webinars, and engage with local health fairs and support groups. Every outreach effort should reflect professionalism and compassion—your brand is built on credibility and care. As opening day approaches, conduct test runs of every system: client intake, documentation workflows, scheduling, medication protocols, and staff coordination. Consider a soft opening with a small group of clients to refine your process. Host orientation sessions for staff and align on emergency responses, documentation standards, and communication protocols. Hold daily debriefs during the first few weeks to identify and solve problems quickly. A focused, well-prepared launch builds confidence among staff and credibility in your community from day one. Success doesn't stop at opening. Establish key performance indicators (KPIs) to track admissions, client progress, staff efficiency, and billing accuracy. Schedule internal audits, client satisfaction surveys, and program reviews regularly. Aim for accreditation through CARF or The Joint Commission to boost your center's reputation and payer eligibility. Reinvest in staff development, facility improvements, and service expansion based on real-time data and evolving needs. A culture of continuous improvement turns a startup into a sustainable center of excellence. As the demand for mental health and addiction services continues to rise, industry leaders are exploring new ways to scale and innovate. Aligning with larger networks or acquiring smaller providers can help organizations expand their reach and improve service delivery. Behavioral health mergers and acquisitions have become a driving force behind this transformation, offering opportunities to consolidate resources, enhance clinical capabilities, and achieve operational efficiency. These transactions require careful planning, regulatory compliance, and cultural alignment to be successful. With the right strategy, such integrations can strengthen community impact while delivering long-term financial and clinical benefits. Launching a rehab center is a demanding but deeply rewarding endeavor. It requires a combination of clinical integrity, business structure, and unwavering commitment to client care. By taking deliberate, practical steps—from licensure and staffing to marketing and quality assurance—you lay the groundwork for a facility that changes lives. When purpose is backed by preparation, your dream evolves into a thriving, trusted place of healing that your community can depend on for years to come. TIME BUSINESS NEWS
Business Wire
09-07-2025
- Business Wire
Kaneka Obtains Halal Certificate for KANEKA UBIQUINOL TM
TOKYO--(BUSINESS WIRE)--Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Kazuhiko Fujii) (TOKYO:4118) has obtained 'Halal Certificate (Certification Number: 355-TSRI/24)' for its functional food ingredient, KANEKA UBIQUINOL TM (active form of coenzyme Q10) powder, under the assessment of Shariah Research Institute of Takushoku University, and issued by JAPAN MUSLIM ASSOCIATION, a religious corporation, on May 28. Halal certification is a system in which relevant organizations verify that products or services do not contain ingredients prohibited under Shariah (Islamic law) and certify their compliance with Shariah. We actively pursue the acquisition of various certifications to ensure the safety and security of our raw materials, and we are pleased to announce that we have obtained a Halal Certificate for KANEKA UBIQUINOL TM. Currently, the Muslim population worldwide is approximately 1.9 billion, and it is estimated to reach 2.2 billion by 2030. In Southeast Asian countries such as Malaysia and Indonesia, where Muslims coexist with people of other faiths, strict standards and regulations have been introduced to ensure the safety and transparency of raw materials used, and the importance of Halal certification is increasing. With the acquisition of this Halal certificate, we expect to expand sales, particularly in Southeast Asia. Based on our mission of KANEKA thinks "Wellness First", we will continue to respond to various needs by providing high-quality products, services and value to make society healthier. Our goal is to enrich people's lives and make society more comfortable in a wide range of fields.
Medscape
03-07-2025
- Medscape
Rheumatoid Nodules: Rare, Recurrent, and Still a Challenge
Despite the rising incidence of rheumatoid arthritis (RA), extra-articular manifestations have become rare in the era of modern treat-to-target therapy. However, they still present clinical challenges — particularly in the case of rheumatoid nodules. In addition to the need to rule out serious differential diagnoses and address potential complications, especially those involving the lungs, these recurrent inflammatory granulomas can affect daily life not only cosmetically but also functionally. Christopher Edwards, MD, professor of rheumatology at University Hospital Southampton in Southampton, England, discussed the clinical relevance and management of rheumatoid nodules during the 2025 Annual Meeting of the European Alliance of Associations for Rheumatology. When Edwards began his career in rheumatology, the presence of rheumatoid nodules was considered a key diagnostic criterion for RA. If not found on the hands, clinicians often examined the elbows and Achilles tendons, which are also common sites. Histologically, rheumatoid nodules are granulomatous inflammatory lesions that evolve through multiple stages. While often subcutaneous, they can also be found on the sclera, larynx, heart valves, and — most significantly — in the lungs. Biopsy When Malignancy Is Suspected Pulmonary nodules can present diagnostic difficulties. 'I've seen patients who were initially told they had lung metastases,' Edwards recalled. Waiting for further imaging and biopsy can be highly distressing for patients. Granulomatosis with polyangiitis can also resemble rheumatoid nodules, further complicating the diagnosis. It is especially important to distinguish these nodules from infections such as tuberculosis. Patients with RA are at increased risk for infection due to both the underlying disease and immunosuppressive treatment. Like tuberculomas, pulmonary rheumatoid nodules can undergo central necrosis when exposed to tumor necrosis factor-alpha inhibitors, leading to cavitation or even pneumothorax. 'Any cavity in the lung can become infected,' Edwards cautioned. Diagnosing Peripheral Nodules Diagnosing peripheral rheumatoid nodules is usually straightforward. These nodules typically feel rubbery on palpation and are movable relative to the underlying tissue. Important differential diagnoses include gouty tophi, lipomas, epidermoid cysts, infectious granulomas, sarcoidosis, and neoplastic lesions. Imaging tools such as ultrasound or fine-needle aspiration can help clarify the diagnosis, particularly when gout is suspected. 'Biopsy is rarely required — only if there's concern about a neoplastic or malignant process,' Edwards explained. Better Disease Control, Fewer Nodules 'In my practice, I see very few nodules these days,' said Edwards. Epidemiological data support this trend: The 10-year cumulative incidence of subcutaneous nodules in RA patients decreased from 30.9% between 1985 and 1999 to 15.8% between 2000 and 2014. Multiple factors likely contributed to this decline, including the earlier initiation of more effective therapies and a reduction in smoking rates. Smoking remains a major risk factor for nodule development, along with long-standing, severe RA, male sex, and seropositivity for rheumatoid factor or anti-cyclic citrullinated peptide antibodies. 'Patients with nodules are almost always seropositive,' Edwards noted. These findings suggest that maintaining tight control of disease activity is more critical for preventing nodules than concerns about drug-induced nodulosis. Little Reason to Discontinue Methotrexate 'There was a time when we worried that methotrexate might be causing nodules,' Edwards said, referring to anecdotal reports of increased nodulosis after initiating methotrexate (MTX). 'But now we're using more MTX and seeing fewer nodules.' He emphasized that the presence of nodules alone should not prompt discontinuation of MTX. 'It wasn't a reason to stop methotrexate back then, and it's not a reason now — though in some cases, it may justify a more aggressive treatment approach.' Other medications — particularly tumor necrosis factor inhibitors like etanercept — have also been linked to nodule development, though Edwards suggested this may reflect reporting bias. 'It might not be causal,' he said. Often, treatment isn't necessary. 'Sometimes it's just a matter of observation,' Edwards noted. Painful or functionally limiting nodules may be managed with local glucocorticoid injections to reduce discomfort and soften the nodules. However, he admitted he had never personally injected a rheumatoid nodule. He also cautioned against injections over the elbow. 'There's something about the skin and the olecranon bursa that makes infections more likely in that area. I saw one patient who needed plastic surgery after an infection left a significant wound.' Rheumatoid nodules also have a tendency to recur. When to Consider Surgery 'Surgery can benefit some patients,' Edwards said. Surgical removal may be warranted for nodules that ulcerate, become infected, or impair function — such as large nodules on the thumb or fingertip that interfere with gripping. 'Patients are usually happy to regain function, even if the nodule comes back a couple of years later.' Nodules that are consistently irritated by shoes or clothing straps may also merit removal. Pulmonary rheumatoid nodules — unlike subcutaneous ones — often contain B cells and typically respond well to rituximab or abatacept. 'These lung nodules tend to shrink or stabilize with rituximab, and certainly, no new ones seem to develop,' Edwards noted. Case reports and small series have also documented improvement with Janus kinase inhibitors.
